KRYS

KRYS

USD

Krystal Biotech Inc. Common Stock

$203.260+7.795 (3.988%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$195.465

Máximo

$212.980

Mínimo

$195.465

Volume

0.66M

Fundamentos da empresa

Capitalização de mercado

5.9B

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.32M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $122.8Atual $203.260Máximo $212.98

Notícias relacionadas

Analyst Upgrades

Citigroup Maintains Neutral on Krystal Biotech, Raises Price Target to $198

Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech with a Neutral and raises the price target from $166 to $198.

Ver mais
Citigroup Maintains Neutral on Krystal Biotech, Raises Price Target to $198
Analyst Upgrades

Chardan Capital Maintains Buy on Krystal Biotech, Raises Price Target to $220

Chardan Capital analyst Geulah Livshits maintains Krystal Biotech with a Buy and raises the price target from $216 to $220.

Ver mais
Chardan Capital Maintains Buy on Krystal Biotech, Raises Price Target to $220
GlobeNewswire

Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results

$97.8 million in 3Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in 4Q Updated U.S. VYJUVEK label expands eligible patient population and

Ver mais
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.